ELVR

[zar]

"This is an exciting time for all of us here at Pulmonx," commented Mike Baker, President and CEO of Pulmonx. "With the completion of the acquisition of Emphasys Medical, Inc. and 510K clearance of our Chartis System, Pulmonx is poised to become a leader in the treatment of pulmonary disorders such as severe emphysema. These new technologies have the potential to cost-effectively improve the health of literally millions of patients globally and I'm extremely enthusiastic about the opportunity to lead this outstanding team as we work to commercialize these breakthrough products and build a strong franchise in Interventional Pulmonology." finance.boston.com/boston/?GUID=9435638&Page=MEDIAVIEWER

07/15/09 08:06 PM EDT